Treats cerebral folate transport deficiency. ANDA 71199, held by Barr. Leucovorin Calcium.
As of Nov 16, 2026, ANDA 71199 (Leucovorin Calcium), held by Barr, was first approved by FDA on Sep 24, 1987, with 18 approved supplements and 0 published complete response letters.
Leucovorin calcium tablets are a folate analog indicated: To reduce the toxicity of: Methotrexate in adult patients with impaired methotrexate elimination, and Folic acid antagonists or dihydrofolate reductase (DHFR) inhibitors following an overdose in adult patients. For the treatment of cerebral folate transport deficiency in adult and pediatric patients who have a confirmed variant in the folate receptor 1 gene (FOLR1-CFTD). Limitations of Use Leucovorin calcium tablets are not recommended for use in patients with a deficiency of methenyltetrahydrofolate synthetase (MTHFS) because MTHFS is a primary enzyme in the metabolism of leucovorin to 5-methenyltetrahydrofolate.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 24, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Leucovorin CalciumEQ 25MG BASE · tablet;oral | Leucovorin Calcium | Rx |
| May 5, 2026 | Supplement 34Labeling · Standard review | Approved | None posted |
| Dec 26, 2000 | Supplement 19Manufacturing | Approved | None posted |
| Dec 21, 1999 | Supplement 18Manufacturing | Approved | None posted |
| Sep 16, 1999 | Supplement 17Manufacturing | Approved | None posted |
| May 20, 1999 | Supplement 16Manufacturing | Approved | None posted |
| Dec 1, 1998 | Supplement 15Manufacturing | Approved | None posted |
| Sep 8, 1998 | Supplement 14Manufacturing | Approved | None posted |
| Nov 20, 1997 | Supplement 13Labeling | Approved | None posted |
| Jun 20, 1997 | Supplement 12Manufacturing | Approved | None posted |
| Apr 7, 1997 | Supplement 11Manufacturing | Approved | None posted |
| Feb 10, 1995 | Supplement 10Manufacturing | Approved | None posted |
| Dec 23, 1994 | Supplement 9Manufacturing | Approved | None posted |
| Oct 11, 1994 | Supplement 8Manufacturing | Approved | None posted |
| Jul 16, 1992 | Supplement 7Labeling | Approved | None posted |
| Apr 3, 1992 | Supplement 6Manufacturing | Approved | None posted |
| Apr 3, 1992 | Supplement 4Manufacturing | Approved | None posted |
| Feb 22, 1991 | Supplement 2Manufacturing | Approved | None posted |
| Dec 18, 1990 | Supplement 3Labeling | Approved | None posted |
| Sep 24, 1987 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters